Clinical trials are the essential pathway to develop new therapies that treat, prevent, and cure blindness and eye disease. These therapies may also provide better treatment options for those diseases with existing treatments or options for those conditions with no treatment.
Lions Vision Trials, together with the world-class ophthalmologists at the Lions Eye Institute, drives the mission of translating groundbreaking discoveries into sight saving treatments. As a result of our clinical trials, our patients have had the opportunity to receive the most advanced treatment available anywhere in the world and sometimes gain access to new treatments before they are available to the general public.
Lions Vision Trials conducts clinical trials for a spectrum of eye conditions, such as age-related macular degeneration and uveitis. In addition, Lions Vision Trials is committed to supporting the local Perth research community by offering bespoke clinical eye services for non-ophthalmic clinical trials.
As leaders in conducting Phase I to IV ophthalmic clinical trials, Lions Vision Trials supports our global and local research partners to develop new therapies that bring the latest treatment to those in need.
The unique interface between Lions Vision Trials and the Lions Eye Institute’s research and clinical services teams is one of our major strengths. This interface allows Lions Vision Trials to support the full spectrum of translational research by testing laboratory-generated ideas through clinical trials and, if proven to be effective and safe, offer new therapies to patients. These world-class techniques, tools and therapies will then be used in every day clinical practice both locally and globally.
If you would like to know more about clinical trials with Lions Vision Trials and how you could participate, read our most frequently asked questions.
Find information for interested participants.